Abstract
Objective: To investigate whether botulinum toxin type B (BTX-B) is effective in improving function, range of motion (ROM), and reducing forearm spasticity in adults with spastic hemiparesis. Design: A single-site, single-blind prospective study. Setting: Outpatient rehabilitation facility at a university hospital. Participants: 21 subjects with spasticity at the elbow, wrist, or finger who had hemiplegia for at least 6 months. Interventions: Subjects were evaluated for ROM, function, spasticity, and tone preinjection.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
